Trevena
TRVN
$0.39
Share price
-4.40%
Change (1 day)
-39.85%
Change (1 year)
Categories
Trevena (TRVN) Fails to deliver data
Key failure to deliver metrics for Trevena:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.01 M
- Last 3 months FTD volume: $0.02 M
- Last year FTD volume: $1.41 M
Failures to deliver for Trevena (TRVN) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Trevena (TRVN) - since 2022
Volume in USD (price x number of shares), data since 2022Trevena (TRVN) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.02 M | -98.33% |
| 2023 | $1.4 M | 2051.04% |
| 2022 | $0.06 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Amgen AMGN | $65.7 M | $0.18 B | 🇺🇸 USA |
 Merck MRK | $8.48 M | $0.18 B | 🇺🇸 USA |
 Cytokinetics
CYTK | $75.74 M | $97.75 M | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $0.05 M | $0.85 M | 🇺🇸 USA |
 Cara Therapeutics
CARA | $0.04 M | $2.53 M | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | $0.21 B | 🇺🇸 USA |